Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2011-06-28
2011-06-28
Olson, Eric S (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C536S004100, C536S018200
Reexamination Certificate
active
07968522
ABSTRACT:
A method and composition for the prophylaxis or treatment of humans or animals for septic shock and sepsis using a mixture of sophorolipids.
REFERENCES:
patent: 5648343 (1997-07-01), Carlson
patent: 5756471 (1998-05-01), Hillion et al.
patent: 5981497 (1999-11-01), Maingault
patent: 7262178 (2007-08-01), Gross
patent: 2007/0249542 (2007-10-01), Gross
Merriam-Webster's Collegiate Dictionary, Tenth Edition, published 1998 by Merriam-Webster, Inc, pp. 924 and 935.
Casas et al., “Sophorolipid Production byCandida bombicola: Medium Composition and Culture Methods” Journal of Bioscience and Bioengineering (1999) vol. 88, No. 5, pp. 488-494.
Colton Laurence P.
Olson Eric S
Polytechnic Institute of NYU
Smith Risley Tempel Santos LLC
LandOfFree
Treatment and prophylaxis of sepsis and septic shock does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment and prophylaxis of sepsis and septic shock, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment and prophylaxis of sepsis and septic shock will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2680865